Tenax TherapeuticsFRA:YBO0 +14.74%34 FCF Yield % is -11.10 as of Jun. 25, 2026. GuruFocus rates FRA:YBO0 with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 1,418 Biotechnology companies, Tenax Therapeutics ranks worse than 53.17% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Tenax Therapeutics FCF Yield % Related Terms
Tenax Therapeutics FCF Yield % Historical Data
* Premium members only.
The historical data trend for Tenax Therapeutics's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:YBO0 vs RZLT, PRLD, NAGE: FCF Yield % Comparison
For the Biotechnology subindustry, Tenax Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tenax Therapeutics FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tenax Therapeutics's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Tenax Therapeutics's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tenax Therapeutics (FRA:YBO0) has a FCF Yield % of -11.10 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Tenax Therapeutics and its competitors. According to the industry distribution chart, Tenax Therapeutics ranks #754 out of 1418 companies in the Biotechnology industry, placing it in the top 53.2%.
Is Tenax Therapeutics' FCF Yield % too high?
Tenax Therapeutics' current FCF Yield % is -11.10. Based on the distribution chart, Tenax Therapeutics ranks #754 out of 1418 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Tenax Therapeutics has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Tenax Therapeutics' FCF Yield % compare to RZLT and PRLD?
According to the Biotechnology industry distribution chart, Tenax Therapeutics ranks #754 out of 1418 companies for FCF Yield %. This places Tenax Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Tenax Therapeutics and its competitors. Tenax Therapeutics's current FCF Yield % is -11.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenax Therapeutics stock overvalued right now?
Tenax Therapeutics (FRA:YBO0) has a current FCF Yield % of -11.10. The current FCF Yield % is -11.10. Tenax Therapeutics' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Tenax Therapeutics (FRA:YBO0), the current FCF Yield % is -11.10 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
34GF Score
Get the complete analysis for FRA:YBO0
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:YBO0 has been successfully added to your 
